Clinical Trial Update: A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma [Phase 3]

View source ↗

Summary

A randomized Phase III trial comparing Folfirinox to Gemcitabine in locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRINOX
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: UNICANCER | Conditions: Pancreatic Cancer, Carcinoma | Phase 3 | Status: COMPLETED